Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
CIPN - Chemotherapy-Induced Peripheral Neuropathy: early-phase trial registry
3 of 5 indexed CIPN - Chemotherapy-Induced Peripheral Neuropathy trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 3 currently recruiting · #3,391 of 28,707 conditions by registered trial count
CIPN - Chemotherapy-Induced Peripheral Neuropathy: 5 US clinical trials tracked, 3 recruiting.
CIPN - Chemotherapy-Induced Peripheral Neuropathy is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Dana-Farber Cancer Institute, running 3 of these trials.
Enrollment posture brief
Registry condition cipn-chemotherapy-induced-peripheral-neuropathy
OPEN 3 | RECR 60% | LATE 0 | EARLY 1 | RANK #3391 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Acute Kidney Injury (AKI) (60% recruiting · 5 trials)
CIPN - Chemotherapy-Induced Peripheral Neuropathy lists 3 open slots (60% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for CIPN - Chemotherapy-Induced Peripheral Neuropathy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
CIPN - Chemotherapy-Induced Peripheral Neuropathy is recruiting above its size-band peers.
3 of 5 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates CIPN - Chemotherapy-Induced Peripheral Neuropathy research.
Dana-Farber Cancer Institute accounts for 3 of 5 trials (60%). 3 distinct sponsors appear on at least one study for this condition label.
-
Most CIPN - Chemotherapy-Induced Peripheral Neuropathy trials plan to enrol fewer than 100 people.
Median target enrolment is 90 among the 5 trials that report a genuine target (sentinel values excluded). 3 of those (60%) plan for fewer than 100 participants.
-
CIPN - Chemotherapy-Induced Peripheral Neuropathy research is mostly interventional.
5 interventional and 0 observational studies make up this index (100% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Scrambler Therapy for Chemotherapy-Induced Peripheral Neuropathy
Case Comprehensive Cancer Center
NCT07219472
Cryocompression for CIPN
Dana-Farber Cancer Institute
NCT07064798
Scrambler Therapy With Duloxetine-based Usual Care vs Duloxetine-based Usual Care for Chemotherapy-induced Peripheral Neuropathy.
Fox Chase Cancer Center
NCT06914557
The Effect of Electroacupuncture on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)
Dana-Farber Cancer Institute
NCT04917796
The Effect of Yoga on Nerve Pain Caused by Chemotherapy (Chemotherapy-Induced Peripheral Neuropathy)
Dana-Farber Cancer Institute
NCT05121558
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on CIPN - Chemotherapy-Induced Peripheral Neuropathy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on CIPN - Chemotherapy-Induced Peripheral Neuropathy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this CIPN - Chemotherapy-Induced Peripheral Neuropathy page
5 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 CIPN - Chemotherapy-Induced Peripheral Neuropathy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Dana-Farber Cancer Institute sponsors the most CIPN - Chemotherapy-Induced Peripheral Neuropathy trials on record, review their full trial history before evaluating a specific study. See Dana-Farber Cancer Institute's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This CIPN - Chemotherapy-Induced Peripheral Neuropathy condition card totals 5 registered trials; most-linked intervention Scrambler Therapy; top US site state Massachusetts. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.